M.K. Parvez, S. Parveen, Evolution and emergence of pathogenic viruses: past, present, and future. Intervirology 60, 1-7 (2017)

M.A. Garcia-Blanco, B.R. Cullen, Molecular basis of latency in pathogenic human viruses. Science 254, 815-820 (1991)

Anders, J. J., Lanzafame, R. J. & R P. Arany,. Vol. 33183-184 (Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA, 2015).

A. El-Hussein, S.L. Manoto, S. Ombinda-Lemboumba, Z.A. Alrowaili, P. Mthunzi-Kufa, A review of chemotherapy and photodynamic therapy for lung cancer treatment. Anti Cancer Agents Med. Chem. 21, 149-161 (2021)

Y. Zhang, Y. Cui, J. Sun, Z.H. Zhou, Multiple conformations of trimeric spikes visualized on a non-enveloped virus. Nat. Commun. 13, 1-9(2022)

A. Noman et al., Spike glycoproteins: their significance for corona viruses and receptor binding activities for pathogenesis and viral survival. Microb. Pathog. 150, 104719 (2021)

A.M. Almehdi et al., SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies. Infection 49, 855-876 (2021)

R. Motavalli et al., The lethal internal face of the coronaviruses: kidney tropism of the SARS, MERS, and COVID 19 viruses. IUBMB Life 73, 1005-1015 (2021)

A. Almeida, M.A.F. Faustino, M.G. Neves, Antimicrobial photodynamic therapy in the control of COVID-19. Antibiotics 9, 320 (2020)

H. Majiya, O.O. Adeyemi, M. Herod, N.J. Stonehouse, P. Millner, Photodynamic inactivation of non-enveloped RNA viruses. J. Photochem. Photobiol., B 189, 87-94 (2018)

D. Schuster, C. Laggner, T. Langer, Why drugs fail-a study on side effects in new chemical entities. Curr. Pharm. Des. 11, 3545-3559 (2005)

F.G. Njoroge, K.X. Chen, N.-Y. Shih, J.J. Piwinski, Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection. Acc. Chem. Res. 41, 50-59 (2008)

S.A. Amin, S. Banerjee, K. Ghosh, S. Gayen, T. Jha, Protease targeted COVID-19 drug discovery and its challenges: insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors. Bioorg. Med. Chem. 29, 115860 (2021)

C.S. Adamson et al., Antiviral drug discovery: preparing for the next pandemic. Chem. Soc. Rev. 50, 3647-3655 (2021)

M. Gennady et al., Photodynamic action in thin sensitized layers: estimating the utilization of light energy. J. Biomed. Photon. Eng. 7, 40301 (2021)

Janik, E., Bartos, M., Niemcewicz, M., Gorniak, L. & Bijak, M. (s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021).

M. Buonanno, D. Welch, I. Shuryak, D.J. Brenner, Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses. Sci. Rep. 10, 1-8 (2020)

M. Sadraeian et al., Study of viral photoinactivation by UV-C light and photosensitizer using a pseudotyped model. Pharmaceutics 14, 683 (2022)

T. C.-Y. Liu, C.-C. Zeng, J.-L. Jiao, S.-H. Liu, in Third International Conference on Photonics and Imaging in Biology and Medicine. (International Society for Optics and Photonics), pp. 150-154

Y. Liu, Y. Cai, X. Zhang, Induction of caspase-dependent apoptosis in cultured rat oligodendrocytes by murine coronavirus is mediated during cell entry and does not require virus replication. J. Virol. 77, 11952-11963 (2003)

S. Pi, L.R. Seng-Libi, D. Xao-Ping, Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed. Environ. Sci 16, 246-255 (2003)

H. Inagaki, A. Saito, H. Sugiyama, T. Okabayashi, S. Fujimoto, Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation. Emerging Microbes& Infections 9, 1744-1747 (2020)

M. Alsharifi, A. Müllbacher, The [gamma]-irradiated influenza vaccine and the prospect of producing safe vaccines in general. Immunol. Cell Biol. 88, 103 (2010)

G.J. Tobin et al., A novel gamma radiation-inactivated sabin-based polio vaccine. PLoS ONE 15, e0228006 (2020)

R.J. Lowy, G.A. Vavrina, D.D. LaBarre, Comparison of gamma and neutron radiation inactivation of influenza A virus. Antiviral Res. 52, 261-273(2001)

J. Fertey et al., Pathogens inactivated by low-energy-electron irradiation maintain antigenic properties and induce protective immune responses. Viruses 8, 319 (2016)

B. Afrough et al., X-ray inactivation of RNA viruses without loss of biological characteristics. Sci. Rep. 10, 1-10 (2020)

P. Vatter, K. Hoenes, M. Hessling, Blue light inactivation of the enveloped RNA virus Phi6. BMC. Res. Notes 14, 1-5 (2021)

P. Vatter, K. Hoenes, M. Hessling, Photoinactivation of the coronavirus surrogate phi6 by visible light. Photochem. Photobiol. 97, 122-125(2021)

R. Rathnasinghe et al., The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus. Sci. Rep. 11, 1-10 (2021)

S.-W.D. Tsen et al., Ultrashort pulsed laser treatment inactivates viruses by inhibiting viral replication and transcription in the host nucleus. Antiviral Res. 110, 70-76 (2014)

A. Berchtikou, A.A. Greschner, P. Tijssen, M.A. Gauthier, T. Ozaki, Accelerated inactivation of M13 bacteriophage using millijoule femtosecond lasers. J. Biophotonics 13, e201900001 (2020)

D. Kingsley et al., Oxygen-dependent laser inactivation of murine norovirus using visible light lasers. Virol. J 15, 1-8 (2018)

M.Y. Lugongolo, S.L. Manoto, S. Ombinda-Lemboumba, M. Maaza, P. Mthunzi-Kufa, The effects of low level laser therapy on both HIV-1 infected and uninfected TZM-bl cells. J. Biophotonics 10, 1335-1344(2017)

R. Malabi, S. Lebohang Manoto, S. Ombinda-Lemboumba, M. Maaza, P. Mthunzi-Kufa, Laser-enhanced drug delivery of antiretroviral drugs into human immunodeficiency virus-1 infected TZMbl cells. J. Biophotonics 12, e201800424 (2019)

J.-I. Choi et al., Development of microalga Scenedesmus dimorphus mutant with higher lipid content by radiation breeding. Bioprocess Biosyst. Eng. 37, 2437-2444 (2014)

H.S. Seo, Application of radiation technology in vaccines development. Clin. Exp. Vaccine Res. 4, 145-158 (2015)

K. Wetz, K.-O. Habermehl, Specific cross-linking of capsid proteins to virus RNA by ultraviolet irradiation of poliovirus. J. Gen. Virol. 59, 397-401 (1982)

K. Oguma, K. Kanazawa, I. Kasuga, S. Takizawa, Effects of UV irradiation by light emitting diodes on heterotrophic bacteria in tap water. Photochem. Photobiol. 94, 570-576 (2018)

O. S. L. Goncalves, Functional and Structural Effects of UV Light on Biomacromolecules: from basic research to therapeutic applications.(2019).

J. Cadet, T. Douki, Formation of UV-induced DNA damage contributing to skin cancer development. Photochem. Photobiol. Sci. 17, 1816-1841 (2018)

Latarjet, R. (Wiley Online Library, 1968).

K.C. Smith, Photochemical reactions of thymine, uracil, uridine, cytosine and bromouracil in frozen solution and in dried films. Photochem. Photobiol. 2, 503-517 (1963)

F. Bourre, A. Benoit, A. Sarasin, Respective roles of pyrimidine dimer and pyrimidine (6-4) pyrimidone photoproducts in UV mutagenesis of simian virus 40 DNA in mammalian cells. J. Virol. 63, 4520-4524(1989)

J. Simonet, C. Gantzer, Inactivation of poliovirus 1 and F-specific RNA phages and degradation of their genomes by UV irradiation at 254 nanometers. Appl. Environ. Microbiol. 72, 7671-7677 (2006)

S.E. Beck et al., Comparison of UV-induced inactivation and RNA damage in MS2 phage across the germicidal UV spectrum. Appl. Environ. Microbiol. 82, 1468-1474 (2016)

C.A. Smith, J. Baeten, J.-S. Taylor, The ability of a variety of polymerases to synthesize past site-specific cis-syn, trans-syn-II, (6-4), and Dewar Photoproducts of Thymidylyl-(3'→ 5')-thymidine. J. Biol. Chem. 273, 21933-21940 (1998)

C.-W. Lo et al., UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins. Sci. Rep. 11, 1-11 (2021)

M. Sadraeian et al., Photoimmunotherapy using cationic and anionic photosensitizer-antibody conjugates against HIV Env-expressing cells. Int. J. Mol. Sci. 21, 9151 (2020)

P. Pradeep, M. Chulkyoon, Non-thermal plasmas (NTPs) for inactivation of viruses in abiotic environment. Res. J. Biotechnol. 11, 6 (2016)

B.K. Mayer, Y. Yang, D.W. Gerrity, M. Abbaszadegan, The impact of capsid proteins on virus removal and inactivation during water treatment processes. Microbiol. Insights 8, S31441 (2015)

D. Park et al., Inactivation efficiency and mechanism of UV-TiO2 pho-tocatalysis against murine norovirus using a solidified agar matrix. Int. J. Food Microbiol. 238, 256-264 (2016)

A. Cammas et al., Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation of specific mRNAs. Mol. Biol. Cell 18, 5048-5059 (2007)

C.D. Lytle, J.-L. Sagripanti, Predicted inactivation of viruses of relevance to biodefense by solar radiation. J. Virol. 79, 14244-14252(2005)

K. Bedell, A.H. Buchaklian, S. Perlman, Efficacy of an automated multiple emitter whole-room ultraviolet-C disinfection system against coronaviruses MHV and MERS-CoV. Infect. Control Hosp. Epidemiol 37, 598-599 (2016)

C.P. Sabino et al., UV-C (254 nm) lethal doses for SARS-CoV-2. Photodiagn. Photodyn. Ther. 32, 101995 (2020)

M. Biasin et al., UV-C irradiation is highly effective in inactivating SARS-CoV-2 replication. Sci. Rep. 11, 1-7 (2021)

C.S. Heilingloh et al., Susceptibility of SARS-CoV-2 to UV irradiation. Am. J. Infect. Control 48, 1273-1275 (2020)

N. Trivellin et al., UV-based technologies for SARS-CoV2 inactivation: status and perspectives. Electronics 10, 1703 (2021)

T. Minamikawa et al., Quantitative evaluation of SARS-CoV-2 inactivation using a deep ultraviolet light-emitting diode. Sci. Rep. 11, 1-9(2021)

D.E. Brash, UV signature mutations. Photochem. Photobiol. 91, 15-26(2015)

W. Peng, B.R. Shaw, Accelerated deamination of cytosine residues in UV-induced cyclobutane pyrimidine dimers leads to CC→ TT transitions. Biochemistry 35, 10172-10181 (1996)

C. Roy et al., Trends of mutation accumulation across global SARS-CoV-2 genomes: implications for the evolution of the novel coronavirus. Genomics 112, 5331-5342 (2020)

S.S. Wallace, D.L. Murphy, J.B. Sweasy, Base excision repair and cancer. Cancer Lett. 327, 73-89 (2012)

Y.R. Li et al., Mutational signatures in tumours induced by high and low energy radiation in Trp53 deficient mice. Nat. Commun. 11, 1-15 (2020)

A. Leung et al., In vitro inactivation of SARS-CoV-2 using gamma radiation. Appl. Biosafety 25, 157-160 (2020)

Turan, R. D. et al. Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61. 3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice. bioRxiv, 2020.2010. 2028.356667 (2021).

A.J. Hume et al., Inactivation of RNA viruses by gamma irradiation: a study on mitigating factors. Viruses 8, 204 (2016)

R.W. Nims, G. Gauvin, M. Plavsic, Gamma irradiation of animal sera for inactivation of viruses and mollicutes-a review. Biologicals 39, 370-377(2011)

M. Durante et al., Virus irradiation and COVID-19 disease. Front. Phys. 8,415 (2020)

F. Feldmann, W.L. Shupert, E. Haddock, B. Twardoski, H. Feldmann, Gamma irradiation as an effective method for inactivation of emerging viral pathogens. Am. J. Trop. Med. Hyg. 100, 1275 (2019)

A. Müllbacher, G. Ada, R. Tha Ha, Gamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses. Immunol. Cell Biol. 66, 153-157 (1988)

F. Thomas et al., Gamma ray inactivation of some animal viruses. Can. J. Comp. Med. 45, 397 (1981)

Lielausis, L. & Magnetohydrodynamics, M.Atomic Energy Review, vol.13. International Atomic Energy, Vienna, 527Á (1975)

S. Oh et al., Neutralizing monoclonal antibodies to different clades of Influenza A H5N1 viruses. J. Virol. Methods 157, 161-167 (2009)

M. Murphey-Corb et al., A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246, 1293-1297 (1989)

R.B. Moss et al., Cross-clade immune responses after immunization with a whole-killed gp120-Depleted human immunodeficiency virus type-1 immunogen in incomplete Freund's adjuvant (HIV-1 Immunogen, Remune™) in human immunodeficiency virus type-1 seropositive subjects. Viral Immunol. 10, 221-228 (1997)

C.-Y. Kang, C. Michalski. (Google Patents, 2011)

H.W. Sheppard, Inactivated-or killed-virus HIV/AIDS vaccines. Curr. Drug Targets Infect. Disord. 5, 131-141 (2005)

S.S. Martin et al., Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB. Vaccine 28, 1031-1040 (2010)

Y. Furuya, Return of inactivated whole-virus vaccine for superior efficacy. Immunol. Cell Biol. 90, 571-578 (2012)

M. Sadraeian, Z. Molaee, in 2009 second international conference on environmental and computer science. (IEEE), pp. 254-258

F. Liu et al., SARS-CoV-2 inactivation simulation using 14 MeV neutron irradiation. Life 11, 1372 (2021)

E. Pollard, in Advances in Virus Research Vol. 2 (Elsevier, 1954), pp. 109-151

J. Fertey, et al. in Bacterial Vaccines (Springer, 2022), pp. 97-113

V. Brahmakshatriya et al., Preliminary study for evaluation of avian influenza virus inactivation in contaminated poultry products using electron beam irradiation. Avian Pathol. 38, 245-250 (2009)

A. Šagátová, M. Fülöp, M. Pavlovič, K. Sedlačková, V. Nečas, Electronbeam accelerator with conversion to X-rays: optimal radiation type according to application. Radiat. Phys. Chem. 172, 108789 (2020)

B. McEvoy, H. Michel, D. Howell, P. Roxby, X-ray: an effective photon. Biomed. Instrum. Technol. 54, 23-30 (2020)

A. Montgomery, R. Bolle-Reddat, S. Formica, B. Lundahl, G. McDonnell, Regulatory approach for transitioning from gamma ray to X-ray radiation sterilization. Biomed. Instrum. Technol. 55, 58-66 (2021)

C. Beerlage, B. Wiese, A.R. Kausch, M. Arsenijevic, Change in radiation sterilization process from gamma ray to X-ray. Biomed. Instrum. Technol. 55, 78-84 (2021)

G. Turner, E. Squires, H. Murray, Inactivated smallpox vaccine A comparison of inactivation methods. Epidemiol. Infect. 68, 197-210 (1970)

J.M. Hansen, N. Fidopiastis, T. Bryans, M. Luebke, T. Rymer, Radiation sterilization: dose is dose. Biomed. Instrum. Technol. 54, 45-52 (2020)

J. Eakins, B. Afrough, R. Hewson, Monte Carlo modelling of an x-ray chamber for providing inactivation exposures to viruses. J. Radiol. Prot. 41, 962 (2021)

J.H. Oh, H. Yoo, H.K. Park, Y.R. Do, Analysis of circadian properties and healthy levels of blue light from smartphones at night. Sci. Rep. 5, 1-9 (2015)

Y. Wang et al., Antimicrobial blue light inactivation of pathogenic microbes: state of the art. Drug Resist. Updates 33, 1-22 (2017)

R.M. Tomb et al., New proof-of-concept in viral inactivation: virucidal efficacy of 405 nm light against feline calicivirus as a model for norovirus decontamination. Food Environ. Virol. 9, 159-167 (2017)

S. Castelletto, A. Boretti, Viral particle imaging by super-resolution fluorescence microscopy. Chem. Phys. Impact 2, 100013 (2021)

T. Pruitt, C. Carter, X. Wang, A. Wu, H. Liu, Photobiomodulation at different wavelengths boosts mitochondrial redox metabolism and hemoglobin oxygenation: lasers vs. light-emitting diodes in vivo. Metabolites 12, 103 (2022)

S.Y. Tam et al., Review on the cellular mechanisms of low-level laser therapy use in oncology. Front. Oncol. 10, 1255 (2020)

M.Y. Lugongolo, S.L. Manoto, S. Ombinda-Lemboumba, M. Maaza, P. Mthunzi-Kufa, The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells. Biomed. J 44(6 Suppl 1), S37-S47 (2020)

M. Sadraeian et al., Photoinduced photosensitizer-antibody conjugates kill HIV env-expressing cells, also inactivating HIV. ACS Omega 6(25), 16524-16534 (2021)

K.-T. Tsen et al., Studies of inactivation of encephalomyocarditis virus, M13 bacteriophage, and Salmonella typhimurium by using a visible femtosecond laser: insight into the possible inactivation mechanisms. J. Biomed. Opt. 16, 078003 (2011)

S.-W.D. Tsen et al., Studies of inactivation mechanism of non-enveloped icosahedral virus by a visible ultrashort pulsed laser. Virol. J 11, 1-9 (2014)

K.-T. Tsen et al., Photonic approach to the selective inactivation of viruses with a near-infrared subpicosecond fiber laser. J. Biomed. Opt. 14, 064042 (2009)

K.-T. Tsen et al., Inactivation of viruses by laser-driven coherent excitations via impulsive stimulated Raman scattering process. J. Biomed. Opt. 12, 064030 (2007)

S.W.D. Tsen et al., Inactivation of multidrug-resistant bacteria and bacterial spores and generation of high-potency bacterial vaccines using ultrashort pulsed lasers. J. Biophotonics 15, e202100207 (2022)

S.-W.D. Tsen et al., Pathogen reduction in human plasma using an ultrashort pulsed laser. PLoS ONE 9, e111673 (2014)

S.-W.D. Tsen et al., Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment. J. Biomed. Opt. 20, 051008 (2014)

S.-W.D. Tsen et al., Inactivation of enveloped virus by laser-driven protein aggregation. J. Biomed. Opt. 17, 128002 (2012)

S.S. Thompson, M.V. Yates, Bacteriophage inactivation at the air-watersolid interface in dynamic batch systems. Appl. Environ. Microbiol. 65, 1186-1190 (1999)

E.C. Dykeman, O.F. Sankey, Vibrational energy funneling in viruses—simulations of impulsive stimulated Raman scattering in M13 bacteriophage. J. Phys.: Condens. Matter 21, 505102 (2009)

J.C. Wigle et al., No effect of femtosecond laser pulses on M13, E. coli, DNA, or protein. J. Biomed. Optics 19, 015008 (2014)

M. Nazari et al., Plasmonic enhancement of selective photonic virus inactivation. Sci. Rep. 7, 1-10 (2017)

C. Maphanga, S. Ombinda-Lemboumba, S. Manoto, M. Maaza, P. Mthunzi-Kufa, in Optical Interactions with Tissue and Cells XXVIII. 1006205 (International Society for Optics and Photonics)

M. Sadraeian et al., Photoinduced photosensitizer-antibody conjugates kill HIV Env-expressing cells also inactivating HIV. ACS Omega 6, 16524-16534 (2021)

R.T. Aroso et al., Photodynamic inactivation of influenza virus as a potential alternative for the control of respiratory tract infections. J. Photochem. Photobiol. 7, 100043 (2021)

M. Galasso et al., Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion. Nat. Commun. 10, 1-12 (2019)